{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:05:21Z","timestamp":1789913121496,"version":"4.0.1"},"reference-count":174,"publisher":"Knowledge E DMCC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Ophthalmic Vis Res"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/2008-322x.183923","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T03:55:57Z","timestamp":1465790157000},"page":"209","source":"Crossref","is-referenced-by-count":86,"title":["Neuroprotection in glaucoma"],"prefix":"10.18502","volume":"11","author":[{"given":"Azadeh","family":"Doozandeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7770","reference":[{"key":"key-10.4103\/2008-322X.183923-1","first-page":"38","volume-title":"New definitions of glaucoma","author":"Gupta","year":"1997","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-2","first-page":"473","volume-title":"Delayed functional loss in glaucoma.LII Edward Jackson Memorial Lecture","author":"Brubaker","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-3","first-page":"2099","volume-title":"The probability of blindness from open-angle glaucoma","author":"Hattenhauer","year":"1998","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.183923-4","first-page":"77","volume-title":"Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss","author":"Sommer","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-5","doi-asserted-by":"crossref","unstructured":"Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol 1981;99:635-649.","DOI":"10.1001\/archopht.1981.03930010635009"},{"key":"key-10.4103\/2008-322X.183923-6","first-page":"345","volume-title":"Retinal ganglion cell death in glaucoma: The how, the why, and the maybe","author":"Nickells","year":"1996","journal-title":"J Glaucoma"},{"key":"key-10.4103\/2008-322X.183923-7","first-page":"39","volume-title":"Neuronal death in glaucoma","author":"Quigley","year":"1999","journal-title":"Prog Retin Eye Res"},{"key":"key-10.4103\/2008-322X.183923-8","first-page":"S151","volume-title":"Apoptosis of retinal ganglion cells in glaucoma: An update of the molecular pathways involved in cell death","author":"Nickells","year":"1999","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-9","first-page":"453","volume-title":"Cell death during development of the nervous system","author":"Oppenheim","year":"1991","journal-title":"Annu Rev Neurosci"},{"key":"key-10.4103\/2008-322X.183923-10","first-page":"613","volume-title":"Excitatory amino acids as a final common pathway for neurologic disorders","author":"Epstein","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2008-322X.183923-11","first-page":"S18","volume-title":"Oxidative stress in neurodegeneration: Cause or consequence?","author":"Andersen","year":"2004","journal-title":"Nat Med"},{"key":"key-10.4103\/2008-322X.183923-12","first-page":"S102","volume-title":"Neuroprotection in relation to retinal ischemia and relevance to glaucoma","author":"Osborne","year":"1999","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-13","first-page":"730","volume-title":"Glutamate excitotoxicity in glaucoma: Throwing the baby out with the bathwater?","author":"Salt","year":"2006","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/2008-322X.183923-14","first-page":"210","volume-title":"Neuroprotection by memantine against neurodegeneration induced by beta-amyloid (1-40)","author":"Miguel-Hidalgo","year":"2002","journal-title":"Brain Res"},{"key":"key-10.4103\/2008-322X.183923-15","first-page":"852","volume-title":"Comparison of delayed administration of competitive and uncompetitive antagonists in preventing NMDA receptor-mediated neuronal death","author":"Levy","year":"1990","journal-title":"Neurology"},{"key":"key-10.4103\/2008-322X.183923-16","first-page":"250","volume-title":"Histologic changes in the inner retina of albino rats following intravitreal injection of monosodium L-glutamate","author":"Sisk","year":"1985","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-17","first-page":"250","volume-title":"Histologic changes in the inner retina of albino rats following intravitreal injection of monosodium L-glutamate","author":"Sisk","year":"1985","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-18","first-page":"980","volume-title":"Ganglion cell death in glaucoma: What do we really know?","author":"Osborne","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-19","first-page":"1399","volume-title":"Morphological and functional changes in experimental ocular hypertension and role of neuroprotective drugs","author":"Garc\u00eda-Campos","year":"2007","journal-title":"Histol Histopathol"},{"key":"key-10.4103\/2008-322X.183923-20","first-page":"S250","volume-title":"New horizons in neuroprotection","author":"Naskar","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-21","first-page":"3483","volume-title":"Molecular basis of glutamate toxicity in retinal ganglion cells","author":"Sucher","year":"1997","journal-title":"Vision Res"},{"key":"key-10.4103\/2008-322X.183923-22","first-page":"1618","volume-title":"Chronic low-dose glutamate is toxic to retinal ganglion cells.Toxicity blocked by memantine","author":"Vorwerk","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-23","first-page":"31","volume-title":"Neuroprotective effects of bis (7)-tacrine against glutamate-induced retinal ganglion cells damage","author":"Fang","year":"2010","journal-title":"BMC Neurosci"},{"key":"key-10.4103\/2008-322X.183923-24","first-page":"1177","volume-title":"Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia","author":"Kapin","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-25","first-page":"864","volume-title":"Vitreous body glutamate concentration in dogs with glaucoma","author":"Brooks","year":"1997","journal-title":"Am J Vet Res"},{"key":"key-10.4103\/2008-322X.183923-26","first-page":"299","volume-title":"Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma","author":"Dreyer","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-27","first-page":"2633","volume-title":"Vitreal glutamate concentration in monkeys with experimental glaucoma","author":"Carter-Dawson","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-28","first-page":"S38","volume-title":"Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage","author":"Lipton","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-29","first-page":"154","volume-title":"MK801-a neuroprotectant in rat hypertensive eyes","author":"Chaudhary","year":"1998","journal-title":"Brain Res"},{"key":"key-10.4103\/2008-322X.183923-30","first-page":"626","volume-title":"Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo","author":"Guo","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-31","first-page":"527","volume-title":"Prospects for clinically tolerated NMDA antagonists: Open-channel blockers and alternative redox states of nitric oxide","author":"Lipton","year":"1993","journal-title":"Trends Neurosci"},{"key":"key-10.4103\/2008-322X.183923-32","first-page":"1360","volume-title":"Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs","author":"Olney","year":"1989","journal-title":"Science"},{"key":"key-10.4103\/2008-322X.183923-33","first-page":"1515","volume-title":"NMDA antagonist neurotoxicity: Mechanism and prevention","author":"Olney","year":"1991","journal-title":"Science"},{"key":"key-10.4103\/2008-322X.183923-34","first-page":"1063","volume-title":"Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia","author":"Lagr\u00e8ze","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-35","first-page":"2625","volume-title":"Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures","author":"Hare","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-36","doi-asserted-by":"crossref","unstructured":"Danesh-Meyer HV, Levin LA. Neuroprotection: Extrapolating from neurologic diseases to the eye. Am J Ophthalmol 2009;148:186-191.e2.","DOI":"10.1016\/j.ajo.2009.03.029"},{"key":"key-10.4103\/2008-322X.183923-37","first-page":"23646","volume-title":"Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase.Steps toward novel drugs for treating Alzheimer's disease","author":"Pang","year":"1996","journal-title":"J Biol Chem"},{"key":"key-10.4103\/2008-322X.183923-38","first-page":"789","volume-title":"Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE","author":"Wang","year":"1999","journal-title":"Neuroreport"},{"key":"key-10.4103\/2008-322X.183923-39","first-page":"471","volume-title":"Neuroprotection via inhibition of nitric oxide synthase by bis(7)-tacrine","author":"Li","year":"2006","journal-title":"Neuroreport"},{"key":"key-10.4103\/2008-322X.183923-40","first-page":"309","volume-title":"Trapping channel block of NMDA-activated responses by amantadine and memantine","author":"Blanpied","year":"1997","journal-title":"J Neurophysiol"},{"key":"key-10.4103\/2008-322X.183923-41","first-page":"1997","volume-title":"Neuroprotective effect of (-) Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: Involvement of peroxynitrite","author":"El-Remessy","year":"2003","journal-title":"Am J Pathol"},{"key":"key-10.4103\/2008-322X.183923-42","first-page":"8268","volume-title":"Cannabidiol and (-) Delta9-tetrahydrocannabinol are neuroprotective antioxidants","author":"Hampson","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/2008-322X.183923-43","first-page":"CD003120","volume-title":"Ginkgo biloba for cognitive impairment and dementia","author":"Birks","year":"2009","journal-title":"Cochrane Database Syst Re v"},{"key":"key-10.4103\/2008-322X.183923-44","first-page":"S36","volume-title":"Alzheimer's disease and glaucoma: Mechanistic similarities and differences","author":"Ghiso","year":"2013","journal-title":"J Glaucoma"},{"key":"key-10.4103\/2008-322X.183923-45","first-page":"93","volume-title":"Mitochondrial dysfunction and glaucoma","author":"Kong","year":"2009","journal-title":"J Glaucoma"},{"key":"key-10.4103\/2008-322X.183923-46","first-page":"221","volume-title":"Potential role for Ginkgo biloba extract in the treatment of glaucoma","author":"Ritch","year":"2000","journal-title":"Med Hypotheses"},{"key":"key-10.4103\/2008-322X.183923-47","first-page":"458","volume-title":"Oxidative DNA damage in the human trabecular meshwork: Clinical correlation in patients with primary open-angle glaucoma","author":"Sacc\u00e0","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-48","first-page":"474","volume-title":"Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo biloba extract EGb 761","author":"Eckert","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"key-10.4103\/2008-322X.183923-49","first-page":"359","volume-title":"Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma","author":"Quaranta","year":"2003","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.183923-50","first-page":"110","volume-title":"Effect of Ginkgo biloba on visual field and contrast sensitivity in Chinese patients with normal tension glaucoma: A randomized, crossover clinical trial","author":"Guo","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-51","first-page":"495","volume-title":"Efficacy and safety of a Ginkgo biloba extract","author":"Le","year":"2000","journal-title":"Public Health Nutr"},{"key":"key-10.4103\/2008-322X.183923-52","first-page":"390","volume-title":"Ginkgo biloba: An adjuvant therapy for progressive normal and high tension glaucoma","author":"Cybulska-Heinrich","year":"2012","journal-title":"Mol Vis"},{"key":"key-10.4103\/2008-322X.183923-53","first-page":"513","volume-title":"Risk of hemorrhage associated with co-prescriptions for Ginkgo biloba and antiplatelet or anticoagulant drugs","author":"Chan","year":"2011","journal-title":"J Altern Complement Med"},{"key":"key-10.4103\/2008-322X.183923-54","first-page":"771","volume-title":"Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve","author":"Anderson","year":"1974","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-55","first-page":"426","volume-title":"Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey","author":"Minckler","year":"1977","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-56","first-page":"3460","volume-title":"Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats","author":"Quigley","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-57","first-page":"764","volume-title":"Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma","author":"Pease","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-58","unstructured":"Reh TA, McCabe K, Kelley MW, Bermingham-McDonogh O, editors. Growth factors in the treatment of degenerative retinal disorders. John Wiley & Sons, Ltd., Chichester;1996."},{"key":"key-10.4103\/2008-322X.183923-59","first-page":"135","volume-title":"Effects of neurotrophins on the survival and regrowth of injured retinal neurons","author":"Aguayo","year":"1996","journal-title":"Ciba Found Symp"},{"key":"key-10.4103\/2008-322X.183923-60","first-page":"3031","volume-title":"Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells","author":"Johnson","year":"1986","journal-title":"J Neurosci"},{"key":"key-10.4103\/2008-322X.183923-61","first-page":"19","volume-title":"Survival and axonal elongation of adult rat retinal ganglion cells","author":"Thanos","year":"1989","journal-title":"Eur J Neurosci"},{"key":"key-10.4103\/2008-322X.183923-62","first-page":"142","volume-title":"Brain-derived neurotrophic factor signalling in adult pig retinal ganglion cell neurite regeneration in vitro","author":"Bonnet","year":"2004","journal-title":"Brain Res"},{"key":"key-10.4103\/2008-322X.183923-63","first-page":"319","volume-title":"Target-derived and locally derived neurotrophins support retinal ganglion cell survival in the neonatal rat retina","author":"Spalding","year":"2004","journal-title":"J Neurobiol"},{"key":"key-10.4103\/2008-322X.183923-64","first-page":"1416","volume-title":"Exogenous brain-derived neurotrophic factor (BDNF) reverts phenotypic changes in the retinas of transgenic mice lacking the BDNF gene","author":"Arango-Gonz\u00e1lez","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-65","first-page":"2808","volume-title":"Functional evidence that BDNF is an anterograde neuronal trophic factor in the CNS","author":"Fawcett","year":"1998","journal-title":"J Neurosci"},{"key":"key-10.4103\/2008-322X.183923-66","first-page":"249","volume-title":"Brain-derived neurotrophic factor (BDNF) prevents lesion-induced axonal die-back in young rat optic nerve","author":"Weibel","year":"1995","journal-title":"Brain Res"},{"key":"key-10.4103\/2008-322X.183923-67","first-page":"966","volume-title":"BDNF enhances retinal ganglion cell survival in cats with optic nerve damage","author":"Chen","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-68","first-page":"489","volume-title":"Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells.A quantitativein vivo study","author":"Peinado-Ram\u00f3n","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-69","first-page":"3887","volume-title":"Brain-derived neurotrophic factor and neurotrophin-4\/5 stimulate growth of axonal branches from regenerating retinal ganglion cells","author":"Sawai","year":"1996","journal-title":"J Neurosci"},{"key":"key-10.4103\/2008-322X.183923-70","first-page":"3978","volume-title":"Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected M\u00fcller cells temporarily rescues injured retinal ganglion cells","author":"Di","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/2008-322X.183923-71","first-page":"32","volume-title":"Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: A quantitativein vivo study","author":"Parrilla-Reverter","year":"2009","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/2008-322X.183923-72","first-page":"304","volume-title":"Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo","author":"Mey","year":"1993","journal-title":"Brain Res"},{"key":"key-10.4103\/2008-322X.183923-73","first-page":"1760","volume-title":"Retinal neuronal death induced by intraocular administration of a nitric oxide donor and its rescue by neurotrophic factors in rats","author":"Takahata","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-74","first-page":"805","volume-title":"Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture","author":"Meyer-Franke","year":"1995","journal-title":"Neuron"},{"key":"key-10.4103\/2008-322X.183923-75","first-page":"212","volume-title":"Adenovirus-mediated expression of ciliary neurotrophic factor (CNTF) rescues axotomized rat retinal ganglion cells but does not support axonal regeneration in vivo","author":"Weise","year":"2000","journal-title":"Neurobiol Dis"},{"key":"key-10.4103\/2008-322X.183923-76","first-page":"2194","volume-title":"Effect of CNTF on retinal ganglion cell survival in experimental glaucoma","author":"Pease","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-77","first-page":"1637","volume-title":"Artemin augments survival and axon regeneration in axotomized retinal ganglion cells","author":"Omodaka","year":"2014","journal-title":"J Neurosci Res"},{"key":"key-10.4103\/2008-322X.183923-78","first-page":"907","volume-title":"Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor","author":"Unoki","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-79","first-page":"477","volume-title":"IL-6, A1 and A2aR: A crosstalk that modulates BDNF and induces neuroprotection","author":"Per\u00edgolo-Vicente","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"key-10.4103\/2008-322X.183923-80","doi-asserted-by":"crossref","unstructured":"Bartesaghi S, Marinovich M, Corsini E, Galli CL, Viviani B. Erythropoietin: A novel neuroprotective cytokine. Neurotoxicology 2005;26:923-928.","DOI":"10.1016\/j.neuro.2005.01.016"},{"key":"key-10.4103\/2008-322X.183923-81","first-page":"136","volume-title":"CNTF and retina","author":"Wen","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"key-10.4103\/2008-322X.183923-82","first-page":"366","volume-title":"Glutamate-induced neuron death requires mitochondrial calcium uptake","author":"Stout","year":"1998","journal-title":"Nat Neurosci"},{"key":"key-10.4103\/2008-322X.183923-83","first-page":"1","volume-title":"Neurodegeneration in glaucoma: Progression and calcium-dependent intracellular mechanisms","author":"Crish","year":"2011","journal-title":"Neuroscience"},{"key":"key-10.4103\/2008-322X.183923-84","first-page":"75","volume-title":"Neuroprotective effect of calcium channel blocker against retinal ganglion cell damage under hypoxia","author":"Yamada","year":"2006","journal-title":"Brain Res"},{"key":"key-10.4103\/2008-322X.183923-85","first-page":"213","volume-title":"Protective effect of nilvadipine against glutamate neurotoxicity in purified retinal ganglion cells","author":"Otori","year":"2003","journal-title":"Brain Res"},{"key":"key-10.4103\/2008-322X.183923-86","first-page":"1456","volume-title":"Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity","author":"Osborne","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-87","first-page":"96","volume-title":"Calcium channels and their blockers in intraocular pressure and glaucoma","author":"Mayama","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/2008-322X.183923-88","first-page":"283","volume-title":"Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma","author":"Sawada","year":"1996","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.183923-89","first-page":"117","volume-title":"Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure","author":"Koseki","year":"1999","journal-title":"J Glaucoma"},{"key":"key-10.4103\/2008-322X.183923-90","first-page":"2049","volume-title":"A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure","author":"Koseki","year":"2008","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.183923-91","first-page":"257","volume-title":"Glaucoma, capillaries and pericytes 1.Blood flow regulation","author":"Anderson","year":"1996","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/2008-322X.183923-92","first-page":"S161","volume-title":"Ocular blood flow and vision in healthy and glaucomatous eyes","author":"Langham","year":"1994","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-93","first-page":"50","volume-title":"Abnormalities of microcirculation in glaucoma: Facts and hints","author":"Pr\u00fcnte","year":"1998","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-94","first-page":"216","volume-title":"Hypertension, perfusion pressure, and primary open-angle glaucoma.A population-based assessment","author":"Tielsch","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-95","first-page":"3977","volume-title":"Time course of the change in optic nerve head circulation after an acute increase in intraocular pressure","author":"Takayama","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-96","unstructured":"Iwase A, Tomidokoro A, Leung C, Zeitz O, Vingrys A, Schmetterer L, et al. Clinical relevance of ocular blood flow (OBF) measurements including effects of general medications or specific glaucoma treatment. In: Ocular Blood Flow in Glaucoma. Kugler Publications: Amsterdam; 2009. p. 59."},{"key":"key-10.4103\/2008-322X.183923-97","first-page":"105","volume-title":"The role of oxidative stress in glaucoma","author":"Izzotti","year":"2006","journal-title":"Mutat Res"},{"key":"key-10.4103\/2008-322X.183923-98","first-page":"62","volume-title":"Oxidative stress markers in aqueous humor of glaucoma patients","author":"Ferreira","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-99","first-page":"823","volume-title":"Evaluation of oxidative stress markers in aqueous humor of primary open angle glaucoma and primary angle closure glaucoma patients","author":"Goyal","year":"2014","journal-title":"Curr Eye Res"},{"key":"key-10.4103\/2008-322X.183923-100","first-page":"1273","volume-title":"Serum autoantibody against glutathione S-transferase in patients with glaucoma","author":"Yang","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-101","first-page":"877","volume-title":"Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma","author":"Gherghel","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-102","first-page":"580","volume-title":"Role of oxidative stress enzymes in open-angle glaucoma","author":"Yildirim","year":"2005","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/2008-322X.183923-103","first-page":"1447","volume-title":"Mitochondrial complex I defect induces ROS release and degeneration in trabecular meshwork cells of POAG patients: Protection by antioxidants","author":"He","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-104","first-page":"2612","volume-title":"Superoxide is an associated signal for apoptosis in axonal injury","author":"Kanamori","year":"2010","journal-title":"Brain"},{"key":"key-10.4103\/2008-322X.183923-105","first-page":"803","volume-title":"Retinal oxidative stress induced by high intraocular pressure","author":"Moreno","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"key-10.4103\/2008-322X.183923-106","first-page":"4143","volume-title":"Retinal ganglion cell loss in superoxide dismutase 1 deficiency","author":"Yuki","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-107","first-page":"182","volume-title":"Oxidative stress affects cytoskeletal structure and cell-matrix interactions in cells from an ocular tissue: The trabecular meshwork","author":"Zhou","year":"1999","journal-title":"J Cell Physiol"},{"key":"key-10.4103\/2008-322X.183923-108","first-page":"458","volume-title":"Oxidative DNA damage in human trabecular meshwork and its correlation with intraocular pressure and visual field in primary open angle glaucoma","author":"Sacc\u00e0","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-109","first-page":"635","volume-title":"Reduced redox state allows prolonged survival of axotomized neonatal retinal ganglion cells","author":"Geiger","year":"2002","journal-title":"Neuroscience"},{"key":"key-10.4103\/2008-322X.183923-110","first-page":"161","volume-title":"Overexpression of thioredoxins 1 and 2 increases retinal ganglion cell survival after pharmacologically induced oxidative stress, optic nerve transection, and in experimental glaucoma","author":"Caprioli","year":"2009","journal-title":"Trans Am Ophthalmol Soc"},{"key":"key-10.4103\/2008-322X.183923-111","first-page":"3737","volume-title":"Neuroprotective effect of sulfhydryl reduction in a rat optic nerve crush model","author":"Swanson","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-112","first-page":"3177","volume-title":"Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma","author":"Tezel","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-113","first-page":"842","volume-title":"Dietary deficiency of Vitamin E aggravates retinal ganglion cell death in experimental glaucoma of rats","author":"Ko","year":"2010","journal-title":"Curr Eye Res"},{"key":"key-10.4103\/2008-322X.183923-114","first-page":"391","volume-title":"Lipid peroxidation and changes in the ubiquinone content and the respiratory chain enzymes of submitochondrial particles","author":"Forsmark-Andr\u00e9e","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"key-10.4103\/2008-322X.183923-115","first-page":"21","volume-title":"Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10","author":"McCarthy","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"key-10.4103\/2008-322X.183923-116","first-page":"375","volume-title":"Relations between tocopherol depletion and coenzyme Q during lipid peroxidation in rat liver mitochondria","author":"Noack","year":"1994","journal-title":"Free Radic Res"},{"key":"key-10.4103\/2008-322X.183923-117","first-page":"226","volume-title":"Coenzyme Q10 protects retinal cells against oxidative stressin vitro and in vivo","author":"Nakajima","year":"2008","journal-title":"Brain Res"},{"key":"key-10.4103\/2008-322X.183923-118","first-page":"397","volume-title":"Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat","author":"Nucci","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"key-10.4103\/2008-322X.183923-119","first-page":"575","volume-title":"Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection","author":"Russo","year":"2008","journal-title":"Prog Brain Res"},{"key":"key-10.4103\/2008-322X.183923-120","first-page":"1814","volume-title":"Coenzyme Q10 in the human retina","author":"Qu","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-121","first-page":"993","volume-title":"Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma","author":"Lee","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-122","first-page":"391","volume-title":"Effects of coenzyme Q10 in conjunction with vitamin E on retinal-evoked and cortical-evoked responses in patients with open-angle glaucoma","author":"Parisi","year":"2014","journal-title":"J Glaucoma"},{"key":"key-10.4103\/2008-322X.183923-123","first-page":"479","volume-title":"The potential value of natural antioxidative treatment in glaucoma","author":"Mozaffarieh","year":"2008","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-124","first-page":"2299","volume-title":"Characterization of alpha2 adrenergic receptor subtypes in human ocular tissue homogenates","author":"Bylund","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-125","first-page":"S290","volume-title":"Role of alpha-2 adrenergic receptors in neuroprotection and glaucoma","author":"Wheeler","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-126","first-page":"6688","volume-title":"Alpha2-adrenergic receptors and their core involvement in the process of axonal growth in retinal explants","author":"Prokosch","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-127","first-page":"216","volume-title":"Alpha (2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia","author":"Donello","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"key-10.4103\/2008-322X.183923-128","first-page":"758","volume-title":"Human ganglion cells express the alpha-2 adrenergic receptor: Relevance to neuroprotection","author":"Kalapesi","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-129","first-page":"65","volume-title":"Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration","author":"Yoles","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-130","first-page":"4515","volume-title":"Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity","author":"Dong","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-131","first-page":"4","volume-title":"Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons","author":"Lambert","year":"2011","journal-title":"Mol Neurodegener"},{"key":"key-10.4103\/2008-322X.183923-132","first-page":"642","volume-title":"Color Doppler analysis of ocular vessel blood velocity in normal- tension glaucoma","author":"Harris","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-133","first-page":"849","volume-title":"Dysfunctional regulation of ocular blood flow: A risk factor for glaucoma?","author":"Moore","year":"2008","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-134","first-page":"131","volume-title":"The impact of glaucoma medication on parameters of ocular perfusion","author":"Harris","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-135","first-page":"199","volume-title":"Effect of brimonidine tartrate on ocular hemodynamics in healthy volunteers","author":"Jonescu-Cuypers","year":"2001","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.4103\/2008-322X.183923-136","first-page":"88","volume-title":"Randomised controlled trial comparing the effect of brimonidine and timolol on visual field loss after acute primary angle closure","author":"Aung","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-137","first-page":"A prospective, unmasked study","volume-title":"Comparison of the effects of brimonidine 0.2% and timolol 0","author":"Tsai","year":"5&#3","journal-title":""},{"key":"key-10.4103\/2008-322X.183923-138","first-page":"671","volume-title":"A randomized trial of brimonidine versus timolol in preserving visual function: Results from the Low-Pressure Glaucoma Treatment Study","author":"Krupin","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-139","first-page":"CD006539","volume-title":"Neuroprotection for treatment of glaucoma in adults","author":"Sena","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/2008-322X.183923-140","first-page":"501","volume-title":"Inducible nitric oxide synthase in retinal ischemia-reperfusion injury","author":"Hangai","year":"1996","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/2008-322X.183923-141","first-page":"521","volume-title":"Loss of retinal ganglion cells following retinal ischemia: The role of inducible nitric oxide synthase","author":"Neufeld","year":"2002","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/2008-322X.183923-142","first-page":"2884","volume-title":"Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure","author":"Shareef","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-143","first-page":"401","volume-title":"Total retinal nitric oxide production is increased in intraocular pressure-elevated rats","author":"Siu","year":"2002","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/2008-322X.183923-144","first-page":"367","volume-title":"Oxidative and nitrative stress markers in glaucoma","author":"Aslan","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"key-10.4103\/2008-322X.183923-145","first-page":"163","volume-title":"Multifaceted roles of nitric oxide in the lateral geniculate nucleus: From visual signal transduction to neuronal apoptosis","author":"Nucci","year":"2003","journal-title":"Toxicol Lett"},{"key":"key-10.4103\/2008-322X.183923-146","first-page":"178","volume-title":"Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head","author":"Liu","year":"2000","journal-title":"Glia"},{"key":"key-10.4103\/2008-322X.183923-147","first-page":"497","volume-title":"Nitric oxide synthase in the human glaucomatous optic nerve head","author":"Neufeld","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-148","first-page":"495","volume-title":"Pressure influence on mRNA and protein expression of inducible nitric oxide synthase in purified retinal ganglion cells of rats","author":"Hu","year":"2002","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"key-10.4103\/2008-322X.183923-149","first-page":"240","volume-title":"Nitric oxide synthase-2 in human optic nerve head astrocytes induced by elevated pressure in vitro","author":"Liu","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-150","first-page":"9944","volume-title":"Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma","author":"Neufeld","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/2008-322X.183923-151","first-page":"399","volume-title":"Nitric oxide synthase inhibitors protect rat retina against ischemic injury","author":"Geyer","year":"1995","journal-title":"FEBS Lett"},{"key":"key-10.4103\/2008-322X.183923-152","first-page":"448","volume-title":"Neuroprotective properties of cannabinoids against oxidative stress: Role of the cannabinoid receptor CB1","author":"Marsicano","year":"2002","journal-title":"J Neurochem"},{"key":"key-10.4103\/2008-322X.183923-153","first-page":"49","volume-title":"HU-211, a nonpsychotropic cannabinoid, produces short- and long-term neuroprotection after optic nerve axotomy","author":"Yoles","year":"1996","journal-title":"J Neurotrauma"},{"key":"key-10.4103\/2008-322X.183923-154","first-page":"1313","volume-title":"Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage","author":"Pang","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-155","first-page":"108","volume-title":"Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA\/2J glaucoma model","author":"Libby","year":"2007","journal-title":"BMC Neurosci"},{"key":"key-10.4103\/2008-322X.183923-156","first-page":"904","volume-title":"Oral administration of SC-51, a nitric oxide synthase inhibitor, does not protect optic nerve axons in a hypertensive rat model of glaucoma","author":"Kasmala","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-157","first-page":"2732","volume-title":"Expression of neuronal nitric oxide synthase in the retina of a rat model of chronic glaucoma","author":"Park","year":"2007","journal-title":"Vision Res"},{"key":"key-10.4103\/2008-322X.183923-158","first-page":"212","volume-title":"Vascular dysregulation: A principal risk factor for glaucomatous damage?","author":"Flammer","year":"1999","journal-title":"J Glaucoma"},{"key":"key-10.4103\/2008-322X.183923-159","first-page":"43","volume-title":"New insights in the pathogenesis and treatment of normal tension glaucoma","author":"Mozaffarieh","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"key-10.4103\/2008-322X.183923-160","first-page":"1270","volume-title":"Dorzolamide effect on ocular blood flow","author":"Martinez","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-161","first-page":"4410","volume-title":"Effect of latanoprost on choroidal blood flow regulation in healthy subjects","author":"Boltz","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-162","first-page":"31","volume-title":"The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma","author":"McKibbin","year":"1999","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/2008-322X.183923-163","first-page":"113","volume-title":"In vivo andin vitro experiments show that betaxolol is a retinal neuroprotective agent","author":"Osborne","year":"1997","journal-title":"Brain Res"},{"key":"key-10.4103\/2008-322X.183923-164","first-page":"331","volume-title":"Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina","author":"Osborne","year":"1999","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/2008-322X.183923-165","first-page":"722","volume-title":"Effects of betaxolol on light responses and membrane conductance in retinal ganglion cells","author":"Gross","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.4103\/2008-322X.183923-166","first-page":"611","volume-title":"Suppressive actions of betaxolol on ionic currents in retinal ganglion cells may explain its neuroprotective effects","author":"Hirooka","year":"2000","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/2008-322X.183923-167","first-page":"522","volume-title":"Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels","author":"Melena","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-168","first-page":"333","volume-title":"Current approaches and future prospects for stem cell rescue and regeneration of the retina and optic nerve","author":"Dahlmann-Noor","year":"2010","journal-title":"Can J Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-169","first-page":"78","volume-title":"Cell transplantation approaches to retinal ganglion cell neuroprotection in glaucoma","author":"Johnson","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"key-10.4103\/2008-322X.183923-170","first-page":"99","volume-title":"Olfactory ensheathing glia: Repairing injury to the mammalian visual system","author":"Plant","year":"2011","journal-title":"Exp Neurol"},{"key":"key-10.4103\/2008-322X.183923-171","first-page":"93","volume-title":"Stem cell therapy for glaucoma: Science or snake oil?","author":"Sun","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"key-10.4103\/2008-322X.183923-172","first-page":"699","volume-title":"Microenvironmental considerations in the application of human mesenchymal stem cells in regenerative therapies","author":"Greco","year":"2008","journal-title":"Biologics"},{"key":"key-10.4103\/2008-322X.183923-173","first-page":"105","volume-title":"Stem cells, cancer, and cancer stem cells","author":"Reya","year":"2001","journal-title":"Nature"},{"key":"key-10.4103\/2008-322X.183923-174","first-page":"3006","volume-title":"Molecular mechanisms mediating retinal reactive gliosis following bone marrow mesenchymal stem cell transplantation","author":"Tassoni","year":"2015","journal-title":"Stem Cells"}],"container-title":["Journal of Ophthalmic and Vision Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T09:45:17Z","timestamp":1734428717000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jovr.org\/text.asp?2016\/11\/2\/209\/183923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":174,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"alternative-id":["183923"],"URL":"https:\/\/doi.org\/10.4103\/2008-322x.183923","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726576791.793530510","asserted-by":"object"}]},"ISSN":["2008-322X"],"issn-type":[{"value":"2008-322X","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}